✹The EU-funded MISTRAL project is exploring the gut microbiota in relation to HIV-1, seeking microbiome biomarkers to support development of interventions that mitigate infection and enhance response to vaccines and therapies. In addition, the creation of a publicly accessible database will aid inpatient screening and stratification. A cloud-based tool will also facilitate microbiome interpretation for reseach and clinical purposes.
✹Although the microbiome has been the subject of intense research over recent decades, very few publications have addressed its potential role in HIV/AIDS – and most of these have focused on the genital microbiome. Increasing evidence supports a role for the gut microbiome in immune system disorders, chronic inflammation and accelerated ageing, all hallmarks of HIV-1 infection.
✹ASPHALION is proud Regulatory partner of this EU granted project. Our experts, Christopher Mann and Laura Mendieta took part on the consortium meeting yesterday, where a project follow-up and and update on all working packages was successfully carried out.
✹Also, we are more than happy to share the news with you about the launch of the project´s website:
https://www.mistral-hiv.eu/#first
✹For further information, you can contact us at: info@asphalion.com
